RecruitingNCT06430021
Study of the Value of hPG80 (Circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients With an MEN1 Mutation
Studying Multiple endocrine neoplasia type 1
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centre Hospitalier Universitaire Dijon
- Intervention
- blood sample(biological)
- Enrollment
- 297 enrolled
- Eligibility
- 18-60 years · All sexes
- Timeline
- 2024 – 2026
Study locations (1)
- Chu Dijon Bourgogne, Dijon, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06430021 on ClinicalTrials.govOther trials for Multiple endocrine neoplasia type 1
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04530916Wild Blueberries and Cardiovascular Health in Middle-aged/Older Men and Postmenopausal WomenColorado State University
- RECRUITINGNCT03966612Study and Monitoring of Multiple Endocrine Neoplasia Type 1Centre Hospitalier Universitaire Dijon
- RECRUITINGNCT03348501Study and Follow-up of Multiple Endocrine Neoplasia Type 1Centre Hospitalier Universitaire Dijon
- ACTIVE NOT RECRUITINGNCT03048279Registry for Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2M.D. Anderson Cancer Center